India Considers Different Regulation Policies For APIs, Other drugs
This article was originally published in PharmAsia News
Executive Summary
India regulators plan to separate active pharmaceutical ingredients from other drugs and adopt a policy for each in a bid to gain back the nation's leadership in bulk-drug production that was lost to China.